No. CONOCB2 is non-routine forming and does not consist of opioids, stimulants, or any substances acknowledged to trigger dependence. End users report no withdrawal indicators or tolerance buildup when using the product as directed. Early investigations into conolidine’s analgesic properties are already conducted in animal models. Rodent reports have https://madonnal740qhw5.wikiconversation.com/user